Stock APLS APELLIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Apellis Pharmaceuticals, Inc.

Equities

APLS

US03753U1060

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-09 EDT 		5-day change 1st Jan Change
42.52 USD +0.52% Intraday chart for Apellis Pharmaceuticals, Inc. -10.47% -28.97%
05-09 Apellis Pharmaceuticals Insider Sold Shares Worth $3,341,848, According to a Recent SEC Filing MT
05-08 UBS Adjusts Price Target on Apellis Pharmaceuticals to $85 From $89, Maintains Buy Rating MT
68710fb53c4a3b0f0b3bcea86fc0405.vjbvs__uL9HBIHDta9CVu9Q5RNiCL1cySUrjqiC20WA.zgDei7uocKuGE0KfOZLP844BFvW3axsGJQeZy3bwujr8ZbDarKZ7vbtsJQ~0b9da5942584d4c316fabc0c724044b3
  1. Stock Market
  2. Equities
  3. APLS Stock
  4. Charts Apellis Pharmaceuticals, Inc.
  5. News Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW